Onxeo to Present at BIO International Convention in Boston
Paris (France), May 23, 2018 – 05:45 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a biotechnology company specializing in the development of innovative drugs in oncology, notably against rare or resistant forms of cancer, today announced that Judith Greciet, the Company’s Chief Executive Officer, will present at the 25th BIO International Convention. The conference is being held on June 4-7, 2018, in Boston, MA.
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO). It is attended by more than 1,100 biotechnology and pharmaceutical companies, academic institutions, state biotechnology centers and related organizations across the United States and from over 30 countries worldwide.
Onxeo corporate presentation:
Date: June 4th, 2018
Time: 3 pm EST / 9 pm CEST
Location: Theater 2 - Boston Convention & Exhibition Center: 415 Summer St., Boston, MA